Clinical trial
Phase II Trial of RAD001 in Refractory Colorectal Cancer
NCT00337545 · Swedish Medical Center, Other · Completed
Key facts
| NCT number | NCT00337545 |
|---|---|
| Title | Phase II Trial of RAD001 in Refractory Colorectal Cancer |
| Official title | Phase II Trial of RAD001 in Patients With Refractory Colorectal Cancer |
| Lead sponsor | Swedish Medical Center, Other |
| Collaborators | Novartis Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | RAD001 |
| Enrollment | 22 |
| Start date | May 1, 2006 |
| Completion | Apr 1, 2007 |
| First posted | Jun 16, 2006 |
| Last update posted | Oct 10, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: